| Quarter | Action | Shares change | Est. value change | Δ Own | Shares held | Filing date |
|---|---|---|---|---|---|---|
| Q1 2026 | New | +752K | +$23M | – | 752K | May 14, 2026 |
| Q3 2025 | New | +63K | +$1.5M | – | 63K | Nov 13, 2025 |
| Q1 2023 | New | +115K | +$2.8M | – | 115K | May 12, 2023 |
Yes. As of Q1 2026, Jeremy Grantham disclosed 752K shares of CTRA, worth $26M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Jeremy Grantham first disclosed a CTRA position in Q1 2023; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
The quarter-by-quarter table above shows each sale and reduction Jeremy Grantham disclosed in CTRA. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Jeremy Grantham disclosed 752K shares of CTRA as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Jeremy Grantham's estimated average buy price for CTRA is $30.06, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.